Literature DB >> 2863837

Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin.

R F Mucha, M J Millan, A Herz.   

Abstract

The present study examines the influence of destruction of the medio-basal arcuate hypothalamus (MBH), the primary site of synthesis of central pools of beta-endorphin (beta-EP), upon the aversive properties of naloxone in a conditioned place preference paradigm. Bilateral radiofrequency lesions of the MBH resulted in a pronounced fall in levels of immunoreactive beta-EP in the brain. Lesioned rats, in contrast to non-operated animals, showed a clear reduction in the conditioned place aversion produced by naloxone. However, they showed no loss of the conditioned preference produced by the mu-selective opioid receptor agonist, morphine, or the conditioned aversion produced by the kappa-selective agonist, U50-488. In contrast to the effect of the lesions, suppression of circulating beta-EP by dexamethasone treatment failed to influence conditioning produced by naloxone. Thus, the data indicate that the aversive properties of naloxone are attenuated by disruption of central (but not peripheral) beta-EP activity. We suggest that these properties of naloxone reflect an antagonism of beta-EP activity in the brain. In addition, the data indicate that differing mechanisms underlie the aversive actions of naloxone as compared to U50-488.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863837     DOI: 10.1007/bf00432214

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Activation of hypothalamic beta-endorphin pools by reward induced by highly palatable food.

Authors:  J Dum; C Gramsch; A Herz
Journal:  Pharmacol Biochem Behav       Date:  1983-03       Impact factor: 3.533

2.  Neurotoxic effects of glutamate on mouse area postrema.

Authors:  J W Olney; V Rhee; T D Gubareff
Journal:  Brain Res       Date:  1977-01-14       Impact factor: 3.252

Review 3.  Multiple opiate receptors in peripheral tissue preparations.

Authors:  M Wüster; R Schulz; A Herz
Journal:  Biochem Pharmacol       Date:  1981-07-15       Impact factor: 5.858

4.  Studies on the hyperthermic response of beta-endorphin in mice.

Authors:  J P Huidobro-Toro; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1979-10       Impact factor: 4.030

5.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

6.  Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference.

Authors:  D van der Kooy; R F Mucha; M O'Shaughnessy; P Bucenieks
Journal:  Brain Res       Date:  1982-07-08       Impact factor: 3.252

7.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.

Authors:  R Guillemin; T Vargo; J Rossier; S Minick; N Ling; C Rivier; W Vale; F Bloom
Journal:  Science       Date:  1977-09-30       Impact factor: 47.728

8.  Drug reinforcement studied by the use of place conditioning in rat.

Authors:  R F Mucha; D van der Kooy; M O'Shaughnessy; P Bucenieks
Journal:  Brain Res       Date:  1982-07-08       Impact factor: 3.252

9.  Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning.

Authors:  R F Mucha; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain.

Authors:  J C Finley; P Lindström; P Petrusz
Journal:  Neuroendocrinology       Date:  1981-07       Impact factor: 4.914

View more
  21 in total

1.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Aversive property of opioid receptor blockade in drug-naive mice.

Authors:  R F Mucha; M J Walker
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 3.  Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.

Authors:  Chris P Bailey; Stephen M Husbands
Journal:  Expert Opin Drug Discov       Date:  2014-09-25       Impact factor: 6.098

4.  Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone.

Authors:  D K Rush
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids.

Authors:  R Bals-Kubik; A Herz; T S Shippenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

6.  Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.

Authors:  Jason J Paris; Kate J Reilley; Jay P McLaughlin
Journal:  J Addict Res Ther       Date:  2011-12-24

7.  Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice.

Authors:  Wojciech Solecki; Anna Turek; Jakub Kubik; Ryszard Przewlocki
Journal:  Psychopharmacology (Berl)       Date:  2009-09-29       Impact factor: 4.530

8.  Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.

Authors:  Marc R Azar; Byron C Jones; Gery Schulteis
Journal:  Psychopharmacology (Berl)       Date:  2003-05-29       Impact factor: 4.530

9.  Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward.

Authors:  Ream Al-Hasani; Jordan G McCall; Gunchul Shin; Adrian M Gomez; Gavin P Schmitz; Julio M Bernardi; Chang-O Pyo; Sung Il Park; Catherine M Marcinkiewcz; Nicole A Crowley; Michael J Krashes; Bradford B Lowell; Thomas L Kash; John A Rogers; Michael R Bruchas
Journal:  Neuron       Date:  2015-09-02       Impact factor: 17.173

10.  Discriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learning.

Authors:  Catherine M Davis; Glenn W Stevenson; Fernando Cañadas; Thomas Ullrich; Kenner C Rice; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2008-07-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.